Cargando…
Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications
The incidence of nonalcoholic fatty liver disease (NAFLD) is increasing recently and has become one of the most common clinical liver diseases. Since the pathogenesis of NAFLD has not been completely elucidated, few effective therapeutic drugs are available. As the “second genome” of human body, gut...
Autores principales: | Fang, Jie, Yu, Chen-Huan, Li, Xue-Jian, Yao, Jin-Mei, Fang, Zheng-Yu, Yoon, Soo-Hyun, Yu, Wen-Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679376/ https://www.ncbi.nlm.nih.gov/pubmed/36425787 http://dx.doi.org/10.3389/fcimb.2022.997018 |
Ejemplares similares
-
Gut Dysbiosis in Chagas Disease. A Possible Link to the Pathogenesis
por: de Souza-Basqueira, Marcela, et al.
Publicado: (2020) -
Dysbiosis and Implication of the Gut Microbiota in Diabetic Retinopathy
por: Huang, Yinhua, et al.
Publicado: (2021) -
Dysbiosis of the Gut Microbiome in Lung Cancer
por: Zhuang, He, et al.
Publicado: (2019) -
The Microbiota and It’s Correlation With Metabolites in the Gut of Mice With Nonalcoholic Fatty Liver Disease
por: Gu, Congwei, et al.
Publicado: (2022) -
Corrigendum: The Microbiota and It’s Correlation With Metabolites in the Gut of Mice With Nonalcoholic Fatty Liver Disease
por: Gu, Congwei, et al.
Publicado: (2022)